Mostrar el registro sencillo del ítem

dc.contributor.authorSoriano-Moreno, D.R.es_PE
dc.contributor.authorFernandez-Guzman, D.es_PE
dc.contributor.authorSangster-Carrasco, L.es_PE
dc.contributor.authorQuispe-Vicuña, C.es_PE
dc.contributor.authorGrados-Espinoza, P.es_PE
dc.contributor.authorCcami-Bernal, F.es_PE
dc.contributor.authorMorocho-Alburqueque, N.es_PE
dc.contributor.authorCoba-Villan, N.es_PE
dc.contributor.authorVelasquez-Fernandez, R.es_PE
dc.contributor.authorNieto- Gutierrez, W.es_PE
dc.date.accessioned2026-02-07T14:54:44Z
dc.date.available2026-02-07T14:54:44Z
dc.date.issued2022
dc.identifier.urihttp://hdl.handle.net/20.500.14074/9521
dc.description.abstractObjective This study aimed to evaluate the factors associated with the consumption of drugs without scientific evidence in patients with mild COVID-19 infection in Peru. Methods An analytical cross-sectional study was carried out including 372 adult patients with a history of mild COVID-19 disease. Factors associated with drug consumption were evaluated by Poisson regressions with robust variance adjustment using the bootstrapping resampling method. Results Seventy-two percent consumed some medication without scientific evidence, with antibiotics (71%) and ivermectin for human use (68%) being the most commonly used. Factors associated with the consumption of drugs to treat mild COVID-19 infection were thinking that the drugs are not effective (adjusted prevalence ratio, 0.55; 95% confidence interval, 0.41-0.74) and not being informed about the efficacy of the drugs (adjusted prevalence ratio, 0.48; 95% confidence interval, 0.36-0.65). Conclusions Education of the population seems to be the main factor that increases the consumption of drugs without scientific evidence in the Peruvian population to treat mild COVID-19.es_PE
dc.formatapplication/pdfes_PE
dc.language.isoenges_PE
dc.publisherLippincott Williams and Wilkins.es_PE
dc.relation.ispartofJ Patient Saf 2022;18: e1189–e1195es_PE
dc.relation.ispartofurn:issn:15498417es_PE
dc.relation.ispartofhttps://www.scopus.com/pages/publications/85143379850es_PE
dc.rightsinfo:eu-repo/semantics/openAccesses_PE
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/es_PE
dc.subjectantibiotices_PE
dc.subjectassociated factors (source: MESH)es_PE
dc.subjectCOVID-19es_PE
dc.subjectdrug therapyes_PE
dc.subjectivermectines_PE
dc.subjectSARS-CoV-2es_PE
dc.titleFactors Associated with Drug Consumption Without Scientific Evidence in Patients with Mild COVID-19 in Peru.es_PE
dc.typeinfo:eu-repo/semantics/articlees_PE
dc.type.versioninfo:eu-repo/semantics/publishedVersiones_PE
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.03.05es_PE
dc.identifier.doihttps:// doi.org/10.1097/PTS.0000000000001053es_PE


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/openAccess
Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/openAccess
Universidad Nacional de Cajamarca

Av. Atahualpa 1050, Cajamarca - Perú | Telf. (+51)076-599220

Todos los contenidos de repositorio.unc.edu.pe están bajo la Licencia Creative Commons

repositorio@unc.edu.pe